ECSP034813A - ARILSULFONAMIDS AS ANTIVIRAL AGENTS - Google Patents

ARILSULFONAMIDS AS ANTIVIRAL AGENTS

Info

Publication number
ECSP034813A
ECSP034813A EC2003004813A ECSP034813A ECSP034813A EC SP034813 A ECSP034813 A EC SP034813A EC 2003004813 A EC2003004813 A EC 2003004813A EC SP034813 A ECSP034813 A EC SP034813A EC SP034813 A ECSP034813 A EC SP034813A
Authority
EC
Ecuador
Prior art keywords
antiviral agents
arilsulfonamids
well
substituents
procedures
Prior art date
Application number
EC2003004813A
Other languages
Spanish (es)
Inventor
Joerg Keldenich
Tobias Wunberg
Juergen Reefschlaeger
Kerstin Henninger
Siegfried Raddatz
Armin Kern
Gunther Schmidt
Peter Eckenberg
Wolfgang Bender
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ECSP034813A publication Critical patent/ECSP034813A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

La presente invención muestra que los sustituyentes R1, R2, R3, R4 así como A y X tienen los significados dados, así como a procedimientos para su preparación y a su uso como agentes antivirales, especialmente frente a citomegalovirus.The present invention shows that the substituents R1, R2, R3, R4 as well as A and X have the meanings given, as well as procedures for their preparation and their use as antiviral agents, especially against cytomegalovirus.

EC2003004813A 2001-04-19 2003-10-17 ARILSULFONAMIDS AS ANTIVIRAL AGENTS ECSP034813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19

Publications (1)

Publication Number Publication Date
ECSP034813A true ECSP034813A (en) 2003-12-01

Family

ID=7681939

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004813A ECSP034813A (en) 2001-04-19 2003-10-17 ARILSULFONAMIDS AS ANTIVIRAL AGENTS

Country Status (9)

Country Link
KR (1) KR20030088509A (en)
AR (1) AR034309A1 (en)
CO (1) CO5540388A2 (en)
DE (1) DE10148598A1 (en)
EC (1) ECSP034813A (en)
GT (1) GT200200075A (en)
PE (1) PE20021061A1 (en)
SV (1) SV2003000995A (en)
ZA (1) ZA200307892B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2003262831A1 (en) * 2002-08-23 2004-03-11 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
WO2004058253A1 (en) * 2002-12-18 2004-07-15 Cytovia, Inc. 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
DE10300109A1 (en) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Method for inhibiting replication of herpes viruses
EP1620412A2 (en) 2003-05-02 2006-02-01 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US7410979B2 (en) 2003-11-19 2008-08-12 Rigel Pharmaceuticals, Inc. Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
CA2606106A1 (en) 2005-05-02 2007-03-08 Rigel Pharmaceuticals, Inc. Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (en) 2006-12-30 2008-07-31 Abbott Gmbh & Amp OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
ES2398676T3 (en) 2007-12-07 2013-03-20 Abbott Gmbh & Co. Kg Amidomethyl substituted oxindole derivatives and their use for the production of a drug for the treatment of vasopressin-dependent diseases
KR20100097195A (en) 2007-12-07 2010-09-02 애보트 게엠베하 운트 콤파니 카게 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
ES2455197T3 (en) 2007-12-07 2014-04-14 Abbvie Deutschland Gmbh & Co Kg 5,6-disubstituted oxindole derivatives and their use for the preparation of a medicine for the treatment of vasopressin-dependent diseases
US8703774B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
EP2435080A2 (en) 2009-05-29 2012-04-04 Abbott Laboratories Pharmaceutical compositions for the treatment of pain

Also Published As

Publication number Publication date
ZA200307892B (en) 2004-10-11
KR20030088509A (en) 2003-11-19
DE10148598A1 (en) 2002-10-24
AR034309A1 (en) 2004-02-18
SV2003000995A (en) 2003-03-18
PE20021061A1 (en) 2002-12-12
CO5540388A2 (en) 2005-07-29
GT200200075A (en) 2002-12-24

Similar Documents

Publication Publication Date Title
ECSP034813A (en) ARILSULFONAMIDS AS ANTIVIRAL AGENTS
ECSP045245A (en) N-ARIL-2-OXAZOLIDINONA-5-CARBOXAMIDS AND ITS DERIVATIVES
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ES2094380T3 (en) NEW SUBSTITUTED PYRAZOLILPIRAZOLES, PROCEDURES FOR THEIR PREPARATION, AS WELL AS INTERMEDIATE COMPOUNDS, AND THEIR USE AS HERBICIDES.
SV2004001432A (en) 2-TIO-3,5-DICIANO-4-4FENIL-6-SUBSTITUTED AMINOPIRIDINS AND ITS USE REF. READ 35 640-SV
UY28342A1 (en) NEW COMPOUNDS
UY27222A1 (en) PIRAZOLOPIRIMIDINAS AS THERAPEUTIC AGENTS
HN2002000300A (en) NEW DERIVATIVES OF PIPERAZINA
UY27761A1 (en) DERIVATIVES OF ACIL-4-CARBOXIFENILUREA, PROCEDURES FOR PREPARATION AND USE.
CY1105386T1 (en) BENZYLSULFONAMIDES AND SULFONYLBENZAMIDINES FOR USE AS ANTI-BULK AGENTS
NO20024153L (en) 2,4-di (hetero-) arylamino (-oxy) -5-substituted pyrimidines as antineoplastic agents
ECSP066481A (en) FORMULATIONS CONTAINING COPPER
ES2165523T3 (en) DERIVATIVES OF CICLOPENTANO-1,3-DIONA.
PA8575601A1 (en) PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE THESE COMPOUNDS AND THEIR USE
UY27263A1 (en) NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS
ECSP044999A (en) ANTIDIABETIC AGENTS
UY28694A1 (en) NEW COMPOUNDS
ECSP066343A (en) 6- (1,1-DIFLUOROALQUIL) -4-AMYNOPYCHOLINATES AND USE AS HERBICIDES
AR035284A1 (en) FORMULATIONS IN COMBINATION OF PROPANOL-AMINA DERIVATIVES SUBSTITUTED WITH ARILO, TOGETHER WITH OTHER ACTIVE SUBSTANCES AND ITS USE
GT199900010A (en) NEW SULFONAMIDES NAFTIL- AND ANILIDO-SUBSTITUTED.
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
ITRM20030363A0 (en) COMPOSITIONS INCLUDING 3, 5DIIODOTYRONINE AND DIESSE PHARMACEUTICAL USE.
AR027575A1 (en) SUBSTITUTED BENZOILCICLOHEXENONAS
PA8557201A1 (en) BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS